Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Janet Pollard

Radiology
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 
18 Years of Experience

Experienced in WT1-Related Wilms Tumor Syndromes
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City, IA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Janet Pollard is a Radiologist in Iowa City, Iowa. Dr. Pollard has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Neuroendocrine Tumor, Smoldering Multiple Myeloma, WT1-Related Wilms Tumor Syndromes, and Renal Cell Carcinoma (RCC).

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2008
Specialties
Radiology
Licenses
Diagnostic Radiology in MO
Hospital Affiliations
Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Christian Hospital Northeast
Missouri Baptist Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellmark
  • HMO
  • POS

Locations

University of Iowa Stead Family Children's Hospital
200 Hawkins Dr, Iowa City, IA 52242
Call: 319-356-3444
Other Locations
Barnes Hospital Washington University
510 S Kingshighway Blvd, Saint Louis, MO 63110
Call: 314-362-7200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Biodistribution of Ga-68 Pentixafor in Patients With Neuroendocrine Tumors
Biodistribution of Ga-68 Pentixafor in Patients With Neuroendocrine Tumors
Enrollment Status: Active_not_recruiting
Publish Date: July 14, 2025
Intervention Type: Drug
Study Drug: GA-68-Pentixafor
Study Phase: Early Phase 1
Clinical Accuracy Assessment of 68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
Clinical Accuracy Assessment of 68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
Enrollment Status: Completed
Publish Date: April 17, 2025
Intervention Type: Drug
Study Drug: Ga-68 Prostate-Specific Membrane Antigen-HBED-CC PET
Study Phase: Phase 2/Phase 3
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug, Other
Study Drug: 177Lu-PSMA-617
Study Phase: Phase 3
68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Ga-68 PSMA-HBED-CC PET
Study Phase: Phase 2/Phase 3
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
Enrollment Status: Completed
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drug: 89Zr-Df-IAB22M2C
Study Phase: Phase 2
68Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients
68Ga PSMA-HBED-CC in Intermediate to High-Risk Preprostatectomy Patients
Enrollment Status: Completed
Publish Date: February 15, 2024
Intervention Type: Drug
Study Drug: Ga-68 PSMA-HBED-CC PET
Study Phase: Phase 2/Phase 3
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
Enrollment Status: Completed
Publish Date: June 14, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

16 Total Publications

Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous Thrombosis.
Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous Thrombosis.
Journal: Clinical nuclear medicine
Published: July 10, 2025
View All 16 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Maheen Rajput
Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Maheen Rajput
Radiology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (219.6 miles away)
319-356-1616
Languages Spoken:
English
See accepted insurances

Maheen Rajput is a Radiologist in Iowa City, Iowa. Dr. Rajput is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Synovial Sarcoma, Neuroendocrine Tumor, Rhabdomyosarcoma Embryonal, and Undifferentiated Pleomorphic Sarcoma.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Catherine Metz
Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Catherine Metz
Radiology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (219.6 miles away)
319-353-7123
Languages Spoken:
English
See accepted insurances

Catherine Metz is a Radiologist in Iowa City, Iowa. Dr. Metz is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Ureterocele, Nonalcoholic Steatohepatitis (NASH), Neuroendocrine Tumor, and WT1-Related Wilms Tumor Syndromes.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Archana Laroia
Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Archana Laroia
Radiology

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (219.6 miles away)
319-356-3375
Experience:
37+ years
Languages Spoken:
English
See accepted insurances

Archana Laroia is a Radiologist in Iowa City, Iowa. Dr. Laroia has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Chronic Cough, Lung Nodules, Synovial Sarcoma, and Rhabdomyosarcoma Embryonal.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pollard's expertise for a condition
ConditionClose
      • Advanced
      • Neuroendocrine Tumor
        Dr. Pollard is
        Advanced
        . Learn about Neuroendocrine Tumor.
        See more Neuroendocrine Tumor experts
      • Experienced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Pollard is
        Experienced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Alveolar Soft Part Sarcoma
        Dr. Pollard is
        Experienced
        . Learn about Alveolar Soft Part Sarcoma.
        See more Alveolar Soft Part Sarcoma experts
      • Ampullary Cancer
        Dr. Pollard is
        Experienced
        . Learn about Ampullary Cancer.
        See more Ampullary Cancer experts
      • Classical Hodgkin Lymphoma
        Dr. Pollard is
        Experienced
        . Learn about Classical Hodgkin Lymphoma.
        See more Classical Hodgkin Lymphoma experts
      • Epithelioid Sarcoma
        Dr. Pollard is
        Experienced
        . Learn about Epithelioid Sarcoma.
        See more Epithelioid Sarcoma experts
      • Fibrosarcoma
        Dr. Pollard is
        Experienced
        . Learn about Fibrosarcoma.
        See more Fibrosarcoma experts
      View All 33 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved